[34th Annual Congress of the American Society of Clinical Oncology. 16-19 May 1998, Los Angeles, USA. Breast cancer (II)].
Conti
F
F
Divisione di Oncologia Medica II, Istituto Regina Elena, Roma, Italia.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D009362:Neoplasm Metastasis; D011379:Prognosis; D013629:Tamoxifen / Q000627:therapeutic use; D014481:United States
D000970:Antineoplastic Agents; D013629:Tamoxifen; D004317:Doxorubicin
XXXIV Congresso Annuale dell'American Society of Clinical Oncology. 16-19 Maggio 1998, Los Angeles, USA. Il tumore della mammella (IIa parte).